BCR anticorps (N-Term)
Aperçu rapide pour BCR anticorps (N-Term) (ABIN2209598)
Antigène
Voir toutes BCR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Humain, Souris, Rat (Rattus)
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo Rt
-
Attributs du produit
- Bcr (Breakpoint Cluster Region Protein, Renal Carcinoma Antigen NY-REN-26, BCR1, D22S11)
-
Purification
- Purified by protein A and immunoaffinity chromatography.
-
Immunogène
- Synthetic peptide (KLH coupled) corresponding to the N-terminal sequence of human Bcr. MW of Antigen: 130, 160kD
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in 10 mM sodium HEPES, pH 7.5, 150 mM sodium chloride, BSA, 50 % glycerol.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 4°C (-20°C Glycerol)
-
-
- BCR (Breakpoint Cluster Region (BCR))
-
Autre désignation
- Bcr
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Platelet-derived growth Factor Receptor Signaling
Antigène
-